These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 1244069)

  • 1. [Behavior of serum triiodothyronine in subjects treated with I-131 for hyperthyroidism].
    Bagnasco M; Biassoni P; Clemente GF; Vibracci G; Ferrini O
    Arch Maragliano Patol Clin; 1975; 31(1):77-87. PubMed ID: 1244069
    [No Abstract]   [Full Text] [Related]  

  • 2. Results of 131I theory for 2,000 thyrotoxic patients: do the effects depend on the dose?
    Zgliczynski S; Gietka-Czernel M; Gorowski T; Bednarski A; Chomicki O; Jastrzebska W; Makowska A; Niegowska E; Pucilowska J; Soszynski P
    Exp Clin Endocrinol; 1991 May; 97(2-3):286-91. PubMed ID: 1915646
    [No Abstract]   [Full Text] [Related]  

  • 3. [Metabolic radiotherapy of hyperthyroidism].
    Salvatore M; Brunetti A
    Ann Ital Chir; 1989; 60(5):367-71. PubMed ID: 2699388
    [No Abstract]   [Full Text] [Related]  

  • 4. [Results obtained in the treatment of hyperfunctional thyroid adenomas with I-131].
    Holan T; Micluţia M; Derevenco V
    Stud Cercet Endocrinol; 1972; 23(4):271-9. PubMed ID: 4681160
    [No Abstract]   [Full Text] [Related]  

  • 5. Results of radioiodine (131/125I) therapy of hyperthyroidism.
    Glanzmann C; Horst W; Magdeburg W
    Radiol Clin (Basel); 1975; 44(5):484-90. PubMed ID: 1208842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Results of 131iodine therapy of benign thyroid diseases (author's transl)].
    Pronath A; Buttermann G; Dirr W; Pabst HW
    MMW Munch Med Wochenschr; 1981 Dec; 123(51-52):1970-4. PubMed ID: 6798434
    [No Abstract]   [Full Text] [Related]  

  • 7. [Hypothyroidism caused by radioiodine therapy].
    Miclulţia M; Derevenco V; Holan T
    Stud Cercet Endocrinol; 1972; 23(4):263-9. PubMed ID: 4681800
    [No Abstract]   [Full Text] [Related]  

  • 8. Early change of thyroid hormone concentration after 131I treatment in patients with solitary toxic adenoma.
    Pirnat E; Fidler V; Zaletel K; Gaberscek S; Hojker S
    Nuklearmedizin; 2002; 41(4):178-83. PubMed ID: 12224401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Results of radioiodine therapy in different forms of hyperthyroidism in relation to the planned dosage].
    Moser E
    Aktuelle Radiol; 1992 Jul; 2(4):179-87. PubMed ID: 1504115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Undetected latrogenic hypothyroidism: a late complication of radio-iodine therapy.
    Smidt KP; Johnston E
    N Z Med J; 1975 Apr; 81(537):325-8. PubMed ID: 1056550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radioiodine therapy in hyperthyroidism: inverse correlation of pretherapeutic iodine uptake level and post-therapeutic outcome.
    Walter MA; Christ-Crain M; Eckard B; Schindler C; Nitzsche EU; Müller-Brand J; Müller B
    Eur J Clin Invest; 2004 May; 34(5):365-70. PubMed ID: 15147334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonimmunogenic hyperthyroidism: cumulative hypothyroidism incidence after radioiodine and surgical treatment.
    Kinser JA; Roesler H; Furrer T; Grütter D; Zimmermann H
    J Nucl Med; 1989 Dec; 30(12):1960-5. PubMed ID: 2585096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiometabolic treatment of hyperthyroidism with a calculated dose of 131-iodine: results of one-year follow-up.
    Regalbuto C; Marturano I; Condorelli A; Latina A; Pezzino V
    J Endocrinol Invest; 2009 Feb; 32(2):134-8. PubMed ID: 19411811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Intravenous or oral 131I treatment of hyperthyroidism and thyroid cancer?].
    Müller KD; Grebe SF; Bock FL; Müller H; Fängewisch GL
    Nuklearmedizin; 1994 Jun; 33(3):87-92. PubMed ID: 8090631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effectiveness of radioactive iodine in the treatment of toxic adenoma: results of our experience with a group of 17 patients and review of the literature].
    Melián E; Cuellar L; Estopiñán V; Riobó P; Lara JI; Sánchez-Franco F
    Med Clin (Barc); 1988 Mar; 90(9):366-8. PubMed ID: 3292865
    [No Abstract]   [Full Text] [Related]  

  • 16. [131I-treatment of the autonomous toxic nodule. Assessment of a fixed dose protocol].
    Abós MD; Banzo J; Razola P; García F; Prats E
    Rev Esp Med Nucl; 1999 Dec; 18(6):431-5. PubMed ID: 10611569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Study of the degradation of labelled thyroxine in patients with hyperthyroidism treated with radioactive iodine].
    Simonin R; Argémi B; Alland A; Paulin R; Bernard PJ
    Ann Endocrinol (Paris); 1970; 31(3):363-6. PubMed ID: 4989456
    [No Abstract]   [Full Text] [Related]  

  • 18. [Discrepancy between peripheral thyroid hormone values and TSH level].
    Heinze HG
    Dtsch Med Wochenschr; 1995 Nov; 120(47):1639-40. PubMed ID: 7493567
    [No Abstract]   [Full Text] [Related]  

  • 19. Serum T3, T4, TSH patterns in euthyroid subjects treated with 131I for thyrotoxicosis.
    Biassoni P; Bagnasco M; Caputo M; Santaniello B; Ferrini O
    J Nucl Med Allied Sci; 1980; 24(1-2):93-8. PubMed ID: 7205396
    [No Abstract]   [Full Text] [Related]  

  • 20. [Results of radioiodine treatment of patients with immunogenic and non-immunogenic hyperthyroidism using different focal doses].
    Moser E; Pickardt CR; Mann K; Engelhardt D; Kirsch CM; Knesewitsch P; Tatsch K; Kreisig T; Kurz C; Saller B
    Nuklearmedizin; 1988 Jun; 27(3):98-104. PubMed ID: 3405782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.